Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mannitol + sodium lactate is an intravenous solution used primarily as an osmotic diuretic and alkalinizing agent. Mannitol, a sugar alcohol, acts by increasing the osmotic pressure of the glomerular filtrate, which inhibits the tubular reabsorption of water and enhances the excretion of sodium and chloride. This osmotic effect is also utilized to shift fluid from the intracellular and interstitial spaces into the intravascular compartment, effectively reducing intracranial and intraocular pressure. Sodium lactate serves as a metabolic precursor to bicarbonate; upon oxidation in the body, it provides an alkalinizing effect that helps to correct metabolic acidosis and maintain acid-base balance. This combination is frequently employed in neurosurgical procedures, trauma management, and as a priming solution in cardiopulmonary bypass to maintain renal function and manage fluid shifts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on mannitol + sodium lactate.